IRadimed Corp reports results for the quarter ended in March - Earnings Summary

IRADIMED

04/05/2023 15:19

* IRadimed Corp  IRMD.OQ  reported quarterly adjusted
earnings of
30 cents​​ per share for the quarter ended in March. The mean
expectation of three analysts for the quarter was for earnings
of 28 cents per share.
    * Revenue rose 25.7% to $15.48 million from a year ago;
analysts
expected $14.77 million. 
    * IRadimed Corp's reported EPS for the quarter was 27
cents​.
    * The mean earnings estimate of analysts had fallen by
about 2.3%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * IRadimed Corp shares had risen by 9.7% this quarter and
gained 57.2% so far this year.
    * The company reported quarterly net income of $3.41
million.
    * Wall Street's median 12-month price target for IRadimed
Corp is
$50.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
4 at 02:18 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      0.28           0.30           Beat
 Dec. 31 2022      0.30           0.32           Beat
 Sep. 30 2022      0.25           0.29           Beat
 Jun. 30 2022      0.24           0.26           Beat